摘要:
目的 :分析头孢他美酯(cefetamet pivoxil)治疗急性泌尿系统感染的临床疗效。 方法 :20例急性泌尿系统感染患者随机分为两组,分别使用头孢他美酯和阿莫西林-克拉维酸钾片(奥格门,Augmemtin)治疗。 A组:头孢他美酯治疗(n=10),每次250mg,早、晚饭后各服1次,B组:阿莫西林-克拉维酸钾片治疗(n=10),每次375mg,每日3次,饭后服用。两组疗程均为 7d。对有效率、痊愈率,尿中白细胞清除率等方面进行评价。 结果 :两组治疗有效率分别为80%和90%;痊愈率分别为70%和80%;尿中白细胞的清除率分别为70%和80%。治疗中B组发生副反应1例。经统计分析,A、B两组间的药效及安全性无显著差异(P>0.05)。 结论 :头孢他美酯是治疗急性泌尿系统感染的有效药物,值得临床推广使用。
Abstract:
Objective : To analyze the clinical curative effects of cefetamet pivoxil on acute urinary system infected patients. Methods :20 acute urinary system infected patients were randomly divided into two groups: group A(n= 10), in which the patients were treated with cefetamet pivoxil(250mg, po, bid, pc) for 7 days, and group B(n= 10), in which the patients were administrated with amoxicillin-clavulante (375mg, po, tid, pc) for7days. The clinical effective rate, recovery rate and WBC clearance rate in urine were statistically evaluated. Results : The clinical effective rates of group A and group B were 80% and 90%, respectively. The recovery rates of group A and group B were 70% and 80%, respectively. The WBC clearance rates in urine of group A and group B were 70% and 80%, respectively. One side effect case occurred in group B. There was no significant difference statistically between two groups (P > 0.05). Conclusion : Cefetamet Pivoxil is efficient to treat acute urinary tract infection.